Skip to main content

TABLE 2.

Mutations in the gyrA QRDR of C. jejuni isolates and MICs of nalidixic acid and ciprofloxacin

Isolate no. State health department of origin gyrA mutation resulting in substitution at:
MIC of:
Amino acid no. 86a Amino acid no. 104b Nalidixic acid Ciprofloxacin
D125 No No 4 0.06
D133c No No 8 0.125
D135 No No 4 0.06
D2295d No No 4 0.03
D2589 No No 8 0.125
D3820 No No 8 0.125
D3836 No No 8 0.06
D4344e Yes No 256 8
CS7 Oreg. No No 16 0.25
CS10 Conn. No No 16 0.25
CS17 Calif. No No 16 0.25
CS18 Oreg. No No 8 0.125
CS54 Minn. No No 8 0.25
CS57 Conn. No No 16 0.25
CS58 Conn. No No 8 0.125
CS59 Conn. No No 8 0.125
CS61 Conn. No No 8 0.125
CS64 Conn. No No 16 0.25
CS89 Calif. No No 8 0.125
CS120 Minn. No No 8 0.06
CS133 Ga. No No 4 0.125
CS5 Oreg. Yes No 512 4
CS8 Conn. Yes No 512 32
CS34 Minn. Yes No 512 32
CS40 Minn. Yes No 512 8
CS42 Minn. Yes No 512 32
CS50 Calif. Yes Yes 256 16
CS71 Oreg. Yes No 512 8
CS82 Conn. Yes No 512 8
CS143 Calif. Yes No 512 16
CS161 Ga. Yes No 512 32
CS165 Ga. Yes No 512 32
CS166 Ga. Yes No 256 8
a

Mutants had a Thr-86-to-Ile (ACA-to-ATA) substitution. 

b

One mutant had a Pro-104-to-Ser (CCA-to-TCA) substitution. 

c

C. jejuni subsp. jejuni ATCC 33560. 

d

C. jejuni subsp. doylei ATCC 49349. 

e

CDC C. jejuni isolate from 1992.